CamMedica

CamMedica (operating as CamMed) is a medical technology firm that developed the Evopump, a highly innovative, flexible patch pump for subcutaneous drug delivery. The Evopump's design is unique for its ultra-thin profile and multi-reservoir architecture, which allows for the precise delivery of complex drug regimens, including biologics and small molecules. This technology addresses the limitations of traditional infusion pumps by providing a more discreet and comfortable solution for patients requiring continuous medication. The company's primary focus has been on applications for diabetes (insulin delivery) and neurological disorders like Parkinson's disease (levodopa delivery). In 2022, CamMedica was acquired by Eoflow, a South Korean wearable medical device company, to integrate its flexible pump technology into Eoflow's next-generation product pipeline.